Sarah McDonald reports on a meta-analysis published yesterday, which found that when compared with active treatment, mindfulness-based cognitive therapy resulted in a reduced risk of depressive relapse.
This blog also features a podcast interview with the lead author of the research, Professor Willem Kuyken.
[read the full story...]
Ioana Cristea takes a closer look at a recent non-inferiority RCT, which compares mindfulness-based cognitive therapy (MBCT) plus discontinued antidepressants versus MBCT and maintenance antidepressants.
[read the full story...]
Guy Goodwin reviews a new paper in the Lancet Psychiatry by Jauhar, McKenna and Laws, that calls into question the trustworthiness of the NICE bipolar disorder guidance.
[read the full story...]
Sarah McDonald appraises a new systematic review that asks if psychological interventions can prevent relapse in adults who have recovered from depression.
[read the full story...]
Raluca Lucacel summarises a meta-analysis of psychological interventions in preventing recurrence of depression, which includes trials on cognitive behavioural therapy, interpersonal therapy and mindfulness-based cognitive therapy.
[read the full story...]
André Tomlin presents the results of the PREVENT RCT published today in The Lancet, which investigates the effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence.
[read the full story...]
Helen Bould summarises a recent review that maps the evidence for the prevention and treatment of eating disorders in young people. Her conclusion? A call to arms for more better quality research to help people affected by these serious illnesses.
[read the full story...]
Approximately 10.6% of individuals with Substance Use Disorders (SUD) in the US seek treatment, with 40-60% relapsing within a year (Dept of Health and Human Services, 2008; McLellan et al, 2000). This highlights a real need for substance abuse treatment that focuses on relapse prevention. This blog summarises a recent RCT from JAMA Psychiatry on [read the full story…]
People with serious mental health issues such as schizophrenia have higher rates of cigarette smoking than the general population, with estimates suggesting more than 50% are current smokers. When people in this population do manage to quit during treatment we then see particularly high rates of relapse after treatment ends. A new randomised control trial (Evins [read the full story…]
During 2010/11 there were 1.53 million hospital admissions for illnesses directly attributable to smoking in the UK. These admissions, along with other smoking-related expenses, cost the NHS approximately £5 billion pounds per year. Fortunately, the NHS is spending £88.2 million per year on cessation treatments, many of which have been repeatedly demonstrated to be highly [read the full story…]
